S A Factor|M P Dentinger - JoVE Visualize

Showing results (61-70 of 93) with videos related to

Pageof 10

Sort By:

Archives of Neurology|September 18, 2001

A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for parkinsonian off-state eventsR B Dewey, J T Hutton, P A LeWitt, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989

Hemichorea-hemiballismus associated with acquired immune deficiency syndrome and cerebral toxoplasmosisJ R Sanchez-Ramos, S A Factor, W J Weiner, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990

Sleep disorders and sleep effect in Parkinson's diseaseS A Factor, T McAlarney, J R Sanchez-Ramos, et al.

Journal of Consulting and Clinical Psychology|August 1, 1991

The role of home practice in thermal biofeedbackE B Blanchard, N L Nicholson, C L Radnitz, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2001

Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12 week open label extension in the PSYCLOPS trialS A Factor, J H Friedman, M C Lannon, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1989

Efficacy of sinemet CR4 in subgroups of patients with Parkinson's diseaseS A Factor, J R Sanchez-Ramos, W J Weiner, et al.

Parkinsonism & Related Disorders|January 1, 1997

Clinical trials of add-on medications in Parkinson's disease: Efficacy versus usefulnessR A Hauser, T A Zesiewicz, S A Factor, et al.

Applied Psychophysiology and Biofeedback|May 22, 1998

Direction of temperature control in the thermal biofeedback treatment of vascular headacheE B Blanchard, M L Peters, C Hermann, et al.

Clinical Neuropharmacology|October 5, 2001

Long-term comparative experience with tolcapone and entacapone in advanced Parkinson's diseaseS A Factor, E S Molho, P J Feustel, et al.

Acta Neuropathologica|January 1, 1988

Ultrastructural features of a brain injury model in cat. I. Vascular and neuroglial changes and the prevention of astroglial swelling by a fluorenyl (aryloxy) alkanoic acid derivative (L-644,711)K D Barron, M P Dentinger, H K Kimelberg, et al.

Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:

Pageof 10

Archives of Neurology|September 18, 2001

A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for parkinsonian off-state eventsR B Dewey, J T Hutton, P A LeWitt, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989

Hemichorea-hemiballismus associated with acquired immune deficiency syndrome and cerebral toxoplasmosisJ R Sanchez-Ramos, S A Factor, W J Weiner, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990

Sleep disorders and sleep effect in Parkinson's diseaseS A Factor, T McAlarney, J R Sanchez-Ramos, et al.

Journal of Consulting and Clinical Psychology|August 1, 1991

The role of home practice in thermal biofeedbackE B Blanchard, N L Nicholson, C L Radnitz, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2001

Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12 week open label extension in the PSYCLOPS trialS A Factor, J H Friedman, M C Lannon, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1989

Efficacy of sinemet CR4 in subgroups of patients with Parkinson's diseaseS A Factor, J R Sanchez-Ramos, W J Weiner, et al.

Parkinsonism & Related Disorders|January 1, 1997

Clinical trials of add-on medications in Parkinson's disease: Efficacy versus usefulnessR A Hauser, T A Zesiewicz, S A Factor, et al.

Applied Psychophysiology and Biofeedback|May 22, 1998

Direction of temperature control in the thermal biofeedback treatment of vascular headacheE B Blanchard, M L Peters, C Hermann, et al.

Clinical Neuropharmacology|October 5, 2001

Long-term comparative experience with tolcapone and entacapone in advanced Parkinson's diseaseS A Factor, E S Molho, P J Feustel, et al.

Acta Neuropathologica|January 1, 1988

Ultrastructural features of a brain injury model in cat. I. Vascular and neuroglial changes and the prevention of astroglial swelling by a fluorenyl (aryloxy) alkanoic acid derivative (L-644,711)K D Barron, M P Dentinger, H K Kimelberg, et al.

Pageof 10